178 related articles for article (PubMed ID: 23077301)
1. Dissection of functional sites in herpesvirus saimiri complement control protein homolog.
Reza MJ; Kamble A; Ahmad M; Krishnasastry MV; Sahu A
J Virol; 2013 Jan; 87(1):282-95. PubMed ID: 23077301
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of the complement control protein homolog of herpesvirus saimiri: ARG-118 is critical for factor I cofactor activities.
Singh AK; Mullick J; Bernet J; Sahu A
J Biol Chem; 2006 Aug; 281(32):23119-28. PubMed ID: 16760474
[TBL] [Abstract][Full Text] [Related]
3. Mapping of functional domains in herpesvirus saimiri complement control protein homolog: complement control protein domain 2 is the smallest structural unit displaying cofactor and decay-accelerating activities.
Singh AK; Yadav VN; Pyaram K; Mullick J; Sahu A
J Virol; 2009 Oct; 83(19):10299-304. PubMed ID: 19640995
[TBL] [Abstract][Full Text] [Related]
4. Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein.
Ahmad M; Raut S; Pyaram K; Kamble A; Mullick J; Sahu A
J Immunol; 2010 Nov; 185(10):6128-37. PubMed ID: 20956343
[TBL] [Abstract][Full Text] [Related]
5. Identification of complement regulatory domains in vaccinia virus complement control protein.
Mullick J; Bernet J; Panse Y; Hallihosur S; Singh AK; Sahu A
J Virol; 2005 Oct; 79(19):12382-93. PubMed ID: 16160165
[TBL] [Abstract][Full Text] [Related]
6. Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8).
Mullick J; Singh AK; Panse Y; Yadav V; Bernet J; Sahu A
J Virol; 2005 May; 79(9):5850-6. PubMed ID: 15827200
[TBL] [Abstract][Full Text] [Related]
7. The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity.
Fodor WL; Rollins SA; Bianco-Caron S; Rother RP; Guilmette ER; Burton WV; Albrecht JC; Fleckenstein B; Squinto SP
J Virol; 1995 Jun; 69(6):3889-92. PubMed ID: 7745740
[TBL] [Abstract][Full Text] [Related]
8. Influence of electrostatics on the complement regulatory functions of Kaposica, the complement inhibitor of Kaposi's sarcoma-associated herpesvirus.
Pyaram K; Kieslich CA; Yadav VN; Morikis D; Sahu A
J Immunol; 2010 Feb; 184(4):1956-67. PubMed ID: 20089702
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of Kaposica reveals that bridging of MG2 and CUB domains of target protein is crucial for the cofactor activity of RCA proteins.
Gautam AK; Panse Y; Ghosh P; Reza MJ; Mullick J; Sahu A
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12794-9. PubMed ID: 26420870
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri.
Rother RP; Rollins SA; Fodor WL; Albrecht JC; Setter E; Fleckenstein B; Squinto SP
J Virol; 1994 Feb; 68(2):730-7. PubMed ID: 7507185
[TBL] [Abstract][Full Text] [Related]
11. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
Blom AM; Kask L; Dahlbäck B
Mol Immunol; 2003 Jan; 39(10):547-56. PubMed ID: 12431388
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the complement inhibitory function of rhesus rhadinovirus complement control protein (RCP).
Okroj M; Mark L; Stokowska A; Wong SW; Rose N; Blackbourn DJ; Villoutreix BO; Spiller OB; Blom AM
J Biol Chem; 2009 Jan; 284(1):505-514. PubMed ID: 18990693
[TBL] [Abstract][Full Text] [Related]
13. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
[TBL] [Abstract][Full Text] [Related]
14. The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system.
Mark L; Lee WH; Spiller OB; Proctor D; Blackbourn DJ; Villoutreix BO; Blom AM
J Biol Chem; 2004 Oct; 279(43):45093-101. PubMed ID: 15304516
[TBL] [Abstract][Full Text] [Related]
15. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
Sahu A; Isaacs SN; Soulika AM; Lambris JD
J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
[TBL] [Abstract][Full Text] [Related]
16. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis.
Fukui A; Yuasa-Nakagawa T; Murakami Y; Funami K; Kishi N; Matsuda T; Fujita T; Seya T; Nagasawa S
J Biochem; 2002 Nov; 132(5):719-28. PubMed ID: 12417021
[TBL] [Abstract][Full Text] [Related]
17. Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.
Mark L; Proctor DG; Blackbourn DJ; Blom AM; Spiller OB
Immunology; 2008 Feb; 123(2):228-38. PubMed ID: 17764451
[TBL] [Abstract][Full Text] [Related]
18. Positively charged amino acids at the interface between alpha-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase.
Blom AM; Zadura AF; Villoutreix BO; Dahlbäck B
Mol Immunol; 2000 Jun; 37(8):445-53. PubMed ID: 11090879
[TBL] [Abstract][Full Text] [Related]
19. Analysis of binding sites on complement factor I that are required for its activity.
Nilsson SC; Nita I; Månsson L; Groeneveld TW; Trouw LA; Villoutreix BO; Blom AM
J Biol Chem; 2010 Feb; 285(9):6235-45. PubMed ID: 20044478
[TBL] [Abstract][Full Text] [Related]
20. Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.
Yadav VN; Pyaram K; Mullick J; Sahu A
J Virol; 2008 Apr; 82(7):3283-94. PubMed ID: 18216095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
